Literature DB >> 23768571

Serum procalcitonin as a biomarker differentiating delayed-type drug hypersensitivity from systemic bacterial infection.

Sun-Young Yoon1, Seung Hee Baek, Sujeong Kim, Yoon Su Lee, Taehoon Lee, Yun-Jeong Bae, Hyouk-Soo Kwon, Jin Won Huh, Sang-Bum Hong, You Sook Cho, Sail Chun, Chae-Man Lim, Younsuck Koh, Hee-Bom Moon, Tae-Bum Kim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23768571     DOI： 10.1016/j.jaci.2013.04.038

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  4 in total

Review 1.  An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity.

Authors:  Ana Copaescu; Andrew Gibson; Yueran Li; Jason A Trubiano; Elizabeth J Phillips
Journal:  Front Pharmacol       Date:  2021-01-12       Impact factor: 5.810

2.  Anaphylactic Reactions Caused by Nafamostat Mesylate during Hemodialysis before Surgery for Carpal Tunnel Syndrome.

Authors:  Yuta Nakamura; Kaoru Tada; Masashi Matsuta; Atsuro Murai; Hiroyuki Tsuchiya
Journal:  Case Rep Nephrol       Date:  2021-12-29

3.  Safety of an extended-release injectable moxidectin suspension formulation (ProHeart® 12) in dogs.

Authors:  Matthew J Krautmann; Sean Mahabir; Ann Fielder; Wendy Collard; Tracie L Wolthuis; Kevin Esch; Tracy Morton; Kent Alleman; Laibin Luo; Erin McCandless; Steven Nederveld; Kristina Kryda; Ryan Carroll; Joseph F Boucher
Journal:  Parasit Vectors       Date:  2019-09-06       Impact factor: 3.876

4.  Procalcitonin -Vital Tool to Differentiate Septic Progression of Spondylodiscitis from Drug Hypersensitivity: A Case Report and Brief Review of Literature.

Authors:  Saurabh Kapoor; Akshay D Gadiya; Fahid T Rasul; David Bell
Journal:  J Orthop Case Rep       Date:  2020
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.